Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03435640
Title A Study of NKTR-262 in Combination With NKTR-214 and With NKTR-214 Plus Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumor Malignancies
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Nektar Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
HonorHealth Scottsdale Arizona 85258 United States Details
UC San Diego Moores Cancer Center La Jolla California 92093 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Winship Cancer Center, Emory University Hospital Atlanta Georgia 30322 United States Details
University of Kansas Research Center Fairway Kansas 66205 United States Details
Henry Ford Health System Detroit Michigan 48202 United States Details
Masonic Cancer Center, University of Minnesota Minneapolis Minnesota 55455 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
Providence Portland Medical Center Portland Oregon 97213 United States Details
University of Texas Southwestern Medical Center Dallas Texas 75390 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field